1. Acute Treatment of Migraine: Expert Consensus Statements from the United Arab Emirates (UAE)

   • Taoufik Alsaadi
   • Deeb M. Kayed
   • Suhail Al-Rukn

   GUIDELINES Open access 19 January 2024 Pages: 257 - 281

   

2. Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives

   • Mark S. Freedman
   • Patricia K. Coyle
   • Anthony T. Reder

   REVIEW Open access 11 January 2024 Pages: 283 - 322

   

3. Impact of Istradefylline on Levodopa Dose Escalation in Parkinson’s Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled Study

   • Taku Hatano
   • Renpei Sengoku
   • Osamu Kano

   ORIGINAL RESEARCH Open access 16 January 2024 Pages: 323 - 338

   

4. Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study

   • Patricia Pozo-Rosich
   • Messoud Ashina
   • Bjørn Sperling

   ORIGINAL RESEARCH Open access 18 January 2024 Pages: 339 - 353

   

5. Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with Schizophrenia

   • Wenyan Wang
   • Xiaofeng Wang
   • Kaoxiang Sun

   ORIGINAL RESEARCH Open access 20 January 2024 Pages: 355 - 372

   

6. Textbook Outcomes Among Patients with Aneurysmal Subarachnoid Hemorrhage Following Endovascular Treatment

   • Zisheng Liu
   • Yuhao Tan
   • Qiao Zuo

   ORIGINAL RESEARCH Open access 23 January 2024 Pages: 373 - 387

   

7. Conversion to Brivaracetam Monotherapy in Clinical Practice: A Retrospective Study

   • Simona Lattanzi
   • Nicoletta Foschi
   • Angelo Labate

   ORIGINAL RESEARCH Open access 01 February 2024 Pages: 389 - 398

   

8. Clinical and Polysomnographic Characteristics of Adult Patients with Suspected Obstructive Sleep Apnea from Different Sleep Clinics at a Single Tertiary Center

   • Eunmi Lee
   • Hyunjo Lee

   ORIGINAL RESEARCH Open access 03 February 2024 Pages: 399 - 414

   

9. Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY)

   • Fabrizio Vernieri
   • Luigi Francesco Iannone
   • Federico Torelli

   ORIGINAL RESEARCH Open access 08 February 2024 Pages: 415 - 435

   

10. Dyskinesia and Pain in Advanced Parkinson’s Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER Study

    • Eric Freire-Alvarez
    • Paola Vanni
    • Olga Sánchez-Soliño

    ORIGINAL RESEARCH Open access 12 February 2024 Pages: 437 - 447

    

11. Understanding the Symptoms and Impacts Experienced by People with Relapsing–Remitting MS: A Qualitative Investigation Using Semi-Structured Interviews

    • Amy Barrett
    • Oyebimpe Olayinka-Amao
    • Paul Kamudoni

    ORIGINAL RESEARCH Open access 12 February 2024 Pages: 449 - 464

    

12. Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study

    • Taoufik Alsaadi
    • Reem Suliman
    • Yazan Bader

    ORIGINAL RESEARCH Open access 15 February 2024 Pages: 465 - 473

    

13. Monitoring of Perioperative Microcirculation Dysfunction by Near-Infrared Spectroscopy for Neurological Deterioration and Prognosis of Aneurysmal Subarachnoid Hemorrhage: An Observational, Longitudinal Cohort Study

    • Shunyan Yang
    • Binbin Tan
    • Lihua Wang

    ORIGINAL RESEARCH Open access 17 February 2024 Pages: 475 - 495